Small (Weinheim an der Bergstrasse, Germany)Jul 20, 2026

Understanding how lipid makeup affects immune response to design nanoparticles with controlled immunity

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Jul 21, 2026

Abstract

Three distinct cytokine programs were identified in lipid nanoparticle formulations that may influence vaccine efficacy and safety.

A monocyte chemoattractant protein-1 (MCP-1)-dominated inflammatory response is associated with cytotoxic stress.
Inflammasome-dependent interleukin-1 beta (IL-1β) secretion requires pro-inflammatory priming.
Type I and II interferon-dependent responses occur when lipid nanoparticles amplify interferon gamma-induced protein 10 (IP-10) production.
Polyethylene glycol-conjugated (PEGylated) lipid content and ionizable lipid identity significantly modulate the interferon gamma/IP-10 axis linked to vaccine-associated myocarditis.
Innate cytokine responses are strongly influenced by lipid composition, while adaptive responses relate more to transgene expression than to cytokine levels.

Simplified

Lipid nanoparticles (LNPs) are central to next-generation vaccines, yet candidate selection remains largely empirical, limiting early identification of formulations associated with rare adverse events such as myocarditis. A better understanding of LNP composition-immunogenicity relationships is therefore critical for rational vaccine design. Here, we profiled a panel of clinically relevant LNP formulations across complementary in vitro and in vivo models to define mechanisms underlying innate immune activation and adaptive responses. We identified three distinct cytokine programs: (i) a monocyte chemoattractant protein-1 (MCP-1)-dominated inflammatory response associated with cytotoxic stress; (ii) inflammasome-dependent interleukin-1 beta (IL-1β) secretion requiring pro-inflammatory priming; and (iii) type I and II interferon-dependent responses in which LNPs synergize with interferon gamma (IFNγ) to amplify interferon gamma-induced protein 10 (IP-10) production. Using a design of experiments (DoE) framework with formulation feature analysis, we found that polyethylene glycol-conjugated (PEGylated) lipid content and ionizable lipid identity are key modulators of the IFNγ/IP-10 axis, previously implicated in vaccine-associated myocarditis. In vivo validation showed that innate cytokine responses are strongly influenced by lipid composition, whereas adaptive humoral and cellular responses correlate with transgene expression rather than cytokine magnitude. Collectively, these findings define relationships among LNP composition, cytokine induction, and vaccine efficacy, and provide a framework for rational design and screening of LNP-based vaccines that maximize immunogenicity while minimizing reactogenicity.

Full Text

Full text is available at the source.

View Full Text ↗

Funding

Competing interests

Belal I. Hanafy, Chuan‐En Lu, Rachel E. Foreman, Ramesh Soundararajan, Sara Marelli, Kai Liu, Philippe Collin, Lennart Lindfors, Alan Sabirsh, Mariarosa Mazza, Stephanie M. Bates, George Thom and Alexander N Kapustin are all current employees of AstraZeneca and may hold shares in AstraZeneca.

PubMed

Featured in

mRNA TechnologyIssue #47

Engineers used AI to design a self-destruct switch that kills virus-infected cells on command

↗

Understanding how lipid makeup affects immune response to design nanoparticles with controlled immunity

Abstract

Full Text

Funding

Competing interests

Featured in

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the mrna technology brief

Abstract

Full Text

Funding

Competing interests

Related papers

Featured in

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the mrna technology brief